Immunodiagnostic Systems Holdings plc provides earnings guidance for the six months ended 30 September 2013. Total revenues are expected to be £27 million representing 13% growth in revenues compared to the prior year equivalent period. The increase in revenue was driven by the continued growth in automated revenues of 37%, compared to the prior year period.
Immunodiagnostic Systems Holdings PLC
Equities
IDH
GB00B01YZ052
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-6.76% | 11.98B | |
-5.68% | 8B | |
+8.91% | 5.85B | |
+28.87% | 5.54B | |
-15.84% | 3.84B | |
+10.70% | 2.66B | |
-60.92% | 2.62B | |
-6.99% | 2.33B | |
+15.67% | 2B |